Article

Uptake of COVID-19 Vaccination in People with Haematological Malignancy and Other High-Risk Blood Disorders: Cohort Analysis of 12 Million Patients in England

2022-10-25

Abstract excerpt

Background: People with blood cancers and other haematological disorders have increased risk of severe outcomes from COVID-19 and were prioritised for vaccination. This study assesses the uptake of COVID-19 vaccines in people with high-risk haematological disorders using QResearch, a UK primary care database.<br><br>Methods: Individuals aged 12 years and above on 1st December 2020 were included in the analysis. Va...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0f9ffb73-4f30-54ef-8e1b-eb97a2744565
DOI: 10.2139/ssrn.4257653

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Uptake of COVID-19 Vaccination in People with Haematological Malignancy and Other High-Risk Blood Disorders: Cohort Analysis of 12 Million Patients in EnglandDOI 10.2139/ssrn.4257653Read

Effectiveness and Safety of COVID-19 Vaccination in People with Blood CancerSemantic proximity Read

Uptake, effectiveness and safety of COVID-19 vaccines in the immunocompromised population: A population-based cohort study in EnglandSemantic proximity Read

Association of Cancer with Risk and Mortality of COVID-19: Results from the UK BiobankSemantic proximity Read

Patients with Hematological Malignancies Treated with T-Cell or B-Cell Immunotherapy Remain at High Risk of Severe Forms of COVID-19 in the Omicron EraSemantic proximity Read

Sociodemographic and Health Factors Affecting Uptake of Second Dose Covid-19 Vaccine in England: Retrospective Cohort Study Using Data from the National Primary Care Sentinel Surveillance Network (Oxford-Royal College of General Practitioners Clinical Informatics Digital Hub)Semantic proximity Read

Scottish COVID CAncer iMmunity Prevalence (SCCAMP) - a longitudinal study of patients with cancer receiving active anti-cancer treatment during the COVID-19 pandemicSemantic proximity Read

Assessing COVID-19 Infection, and Severe Disease Risk in Cancer Patients and Survivors: The Role of Vaccination Status, Circulating Variants, and Comorbidities—A Population-Based Study in Northern ItalySemantic proximity Read

Scottish COVID Cancer Immunity Prevalence (SCCAMP) - a Longitudinal Study of Patients with Cancer Receiving Active Anti-Cancer Treatment During the COVID-19 PandemicSemantic proximity Read

Uptake of COVID-19 vaccination and associated factors among patients attending oncology services in Dar es Salaam, Tanzania: A mixed design methods’ trajectoriesSemantic proximity Read

Seroprevalence study prior and post vaccination in Cancer patients in Principality of Andorra (COVONCO study)Semantic proximity Read

Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELYSemantic proximity Read

Willingness to receive a COVID-19 vaccine among adults at high-risk of COVID-19: a UK-wide surveySemantic proximity Read